Table 1 Patients’ clinical features.
From: miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn’s disease
Characteristics | Normal Control | Crohn’s Disease |
|---|---|---|
(n=20) | (n=20) | |
Gender | ||
male | 11 | 12 |
female | 9 | 8 |
Mean age, years±SD | 36.2±10.0 | 29.2±10.5 |
Mean duration of disease, years±SD | – | 16.3±12.5 |
Diseased intestinal regions | ||
ileum | – | 7 |
ileocolon | – | 9 |
colon | – | 4 |
Treatment | ||
prednisone | – | 8 |
5-AZA+prednisone | – | 7 |
IFX+prednisone | – | 3 |
IFX+AZA | – | 2 |
